The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells

J. Neukirchen, A. Meier, A. Rohrbeck, G. Garcia-Pardillos, U. Steidl, R. Fenk, R. Haas, R. Kronenwett, U. P. Rohr

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells'. Together they form a unique fingerprint.

Medicine & Life Sciences